Looking at the universe of stocks we cover at Dividend Channel, on 1/15/25, Abbott Laboratories (Symbol: ABT), AbbVie Inc (Symbol: ABBV), and Phillips Edison & Co Inc (Symbol: PECO) will all trade ex-dividend for their respective upcoming dividends. Abbott Laboratories will pay its quarterly dividend of $0.59 on 2/14/25, AbbVie Inc will pay its quarterly dividend of $1.64 on 2/14/25, and Phillips Edison & Co Inc will pay its monthly dividend of $0.1025 on 2/4/25. As a percentage of ABT's recent stock price of $112.31, this dividend works out to approximately 0.53%, so look for shares of Abbott Laboratories to trade 0.53% lower — all else being equal — when ABT shares open for trading on 1/15/25. Similarly, investors should look for ABBV to open 0.94% lower in price and for PECO to open 0.29% lower, all else being equal.
Below are dividend history charts for ABT, ABBV, and PECO, showing historical dividends prior to the most recent ones declared.
Abbott Laboratories (Symbol: ABT):
AbbVie Inc (Symbol: ABBV):
Phillips Edison & Co Inc (Symbol: PECO):
In general, dividends are not always predictable, following the ups and downs of company profits over time. Therefore, a good first due diligence step in forming an expectation of annual yield going forward, is looking at the history above, for a sense of stability over time. This can help in judging whether the most recent dividends from these companies are likely to continue. If they do continue, the current estimated yields on annualized basis would be 2.10% for Abbott Laboratories, 3.74% for AbbVie Inc, and 3.46% for Phillips Edison & Co Inc.
In Monday trading, Abbott Laboratories shares are currently down about 1.7%, AbbVie Inc shares are off about 1.9%, and Phillips Edison & Co Inc shares are off about 2.8% on the day.
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »
Also see:
Secondary Stock Offerings
ONEM market cap history
SCIF shares outstanding history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
